Physician profile
Murad Arif
NPI 1164925038
$28,601.66
in general payments reported to CMS, 2019-2025
35 companies · $1,189 in 2025
The $1,189 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,237 · 2021: $4,031 · 2022: $5,053 · 2023: $3,281 · 2024: $1,220 · 2025: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,978 · Travel and Lodging: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,978.26 |
| Travel and Lodging | $711.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $11,250.00 | 2019 | |
| Boston Scientific Corporation | $4,918.17 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $4,836.30 | 2021-2023 | Intellis Adaptivestim, Vanta Adaptivestim, Accurian |
| Biohaven Pharmaceutical Holding Company LTD. | $1,967.73 | 2022 | |
| Nevro Corp. | $1,037.91 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $773.67 | 2022-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $726.53 | 2022-2024 | Relistor |
| Abbvie INC. | $641.54 | 2021-2025 | Qulipta, Ubrelvy |
| Curonix LLC | $547.14 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Merck Sharp & Dohme LLC | $245.72 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $195.39 | 2021-2025 | Ztlido |
| Idorsia Pharmaceuticals US INC | $172.68 | 2023 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $140.36 | 2021 | |
| Avanos Medical | $123.16 | 2021-2025 | Trays- All |
| Pfizer INC. | $121.65 | 2023-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $108.52 | 2020 | |
| Valinor Pharma, LLC | $89.89 | 2024-2025 | Movantik |
| Si-Bone, INC. | $85.81 | 2021-2024 | |
| Vision Quest Industries INC. | $67.80 | 2024 | Avid Ct2 Nmes/Ifc Stimulator, Pro Estim Nmes Stimulator |
| Cumberland Pharmaceuticals, INC. | $66.41 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $61.13 | 2025 | |
| Azurity Pharmaceuticals, INC. | $60.74 | 2023-2025 | Horizant, Horizant |
| Spr Therapeutics, INC | $52.06 | 2025 | Sprint Pns System |
| Stryker Corporation | $45.00 | 2021 | |
| Stimwave Technologies Incorporated | $39.51 | 2020-2022 | |
| Octapharma USA, INC. | $36.83 | 2024 | Fibryga |
| Virtus Pharmaceuticals LLC | $35.72 | 2024 | Levorphanol Tartrate |
| Vertos Medical, INC. | $30.59 | 2023 | Mild Device Kit |
| Pacira Pharmaceuticals Incorporated | $21.38 | 2021 | |
| Painteq LLC | $21.31 | 2023 | Painteq |
| Tonix Medicines, INC. | $19.26 | 2025 | Tonmya |
| Indivior INC. | $17.96 | 2022 | |
| Fidia Pharma USA INC. | $17.33 | 2023 | Hymovis, Triluron |
| Nalu Medical, INC. | $14.97 | 2024 | Nalu Neurostimulation System |
| Arbor Pharmaceuticals, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murad Arif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.